Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
Chinese Medical Ethics ; (6): 103-105, 2015.
Article in Chinese | WPRIM | ID: wpr-461531

ABSTRACT

With a long duration of the CHB, patients who have economic pressures and physical problems will get changes in their psychological status, which are involved in the development of the disease. Moreover, poor thera-py compliance and insight of their disease, negative mood of anxiety and depression also have effects the prognosis of disease. Therefore, mental factors play a vital important role in the development and prognosis of CHB patients, health education and mental intervention are the most effective way to avoid the psychological disorder of patients.

2.
International Journal of Traditional Chinese Medicine ; (6): 504,512-2010.
Article in Chinese | WPRIM | ID: wpr-597180

ABSTRACT

Objective To observe the clinical effects of treating chronic type B hepatitis with Gankang Granule combined with poly I-C and immune ribonucleic acid. Methods A total of 100 cases of chronic type B hepatitis were randomly recruited into a control group and a treatment group, 50 cases in each group. The control group was treated with poly I-C and immune ribonucleic acid, while the treatment group was treated with Gankang Granule on the basis of the control group. Results Symptoms in both groups were improved. 23 eases in the treatment group showed negative value of HBeAg,contrasting to 13 cases in the control group. 38 cases in the treatment group turned to be negative value of HBV- DNA, higher than the number of 23 cases in the control group. The treatment group demonstrated a significantly better therapeutic results than the control group (χ2 value was 6.267 and 6.345 respectively, both P<0.05). Conclusion Gankang Granule combined with poly I-C and immune ribonucleic acid can obviously improve hepatic functions and symptoms of chronic type B hepatitis,shorten the course of disease, and increase the rate of negative value of HBeAg and HBV- DNA.

3.
China Pharmacy ; (12)2005.
Article in Chinese | WPRIM | ID: wpr-525645

ABSTRACT

OBJECTIVE:To observe the therapeutic effect of compound glycyrrhizin with oxymatrine on chronic Type B hepatitis.METHODS:66patients with chronic Type B hepatitis were randomly divided into2groups.The treatment group(36cases)were treated with compound glycyrrhizin with oxymatrine and the control group(30cases)were treated with di?ammonium glycyrrhizinate.The changes of clinical symptoms,signs,hepatic function parameters and liver fibrosis parameters of the two groups were observed after treatment for8weeks.RESULTS:Significant differences were found between the treatment group and the control group in improvements of clinical symptoms,signs,hepatic function parameters and hepatic fibrosis parameters(P

4.
China Pharmacy ; (12)2005.
Article in Chinese | WPRIM | ID: wpr-525422

ABSTRACT

OBJECTIVE:To observe the Therapeutic effect of Man'gan decoction plus compound glycyrrhizin in the trea_ tment of chronic type B hepatitis.METHODS:46patients with chronic hepatitis B were randomly divided into treatment group and control group.The treatment group was treated with self-planned Man'gan decoction for6mo plus compound glycyrrhizin for3mo;the control group received6months'conventional therapy-diammonium glycyrrhizinate,vitamin and amino acid compound injection,etc.RESULTS:At the end of treatment,the hepatic function and hepatic fibrosis index levels of the treatment group were superior to the control group(P

5.
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-527692

ABSTRACT

OBJECTIVE:To observe the curative efficacy of compound glycyrrhizin in the treatment of chronic type B hepatitis.METHODS:102patients with type B hepatitis were randomly selected to receive compound glycyrrhizin60ml by in-travenous drip infusion once daily for30days.The clinical symptoms,signs,and indexes of hepatic function and hepatic fibrosis were observed before and after treatment.RESULTS:As compared with treatment before,patients’symptoms,signs,indexes of hepatic function and hepatic fibrosis all had obvious amelioration after treatment(P

6.
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-524963

ABSTRACT

OBJECTIVE:To observe on the curative effect of compound glycyrrhizin in the treatment of chronic hepatitis B with hepatic fibrosis.METHODS:146cases of chronic hepatitis B with hepatic fibrosis were administered by i.v.drop daily for4weeks with compound glycyrrhizin injection40ml~100ml,into which5%glucose injection(250ml)was added,then a sequential therapy was adopted in which all the patients were treated with50mg oral compound glycyrrhizin tablets3times per day for3months.RESULTS:The total effective rates after4weeks of first stage treatment and the sequential therapy were67.12%and81.51%(P

7.
China Pharmacy ; (12)1991.
Article in Chinese | WPRIM | ID: wpr-527028

ABSTRACT

OBJECTIVE:To observe the effect of compound glycyrrhizin on patients with chronic type B hepatitis.METH_ ODS:126patients with chronic type B hepatitis were randomly divided into two groups:the control group was administered with common therapy like reducing jaundice and protecting liver;the trial group was administered with compound glycyrrhizin plus the therapy of the control group.Time of therapy for both groups was8wk.RESULTS:The total effective rates for the tri_ al group and the control group were93.6%and33.3%,respectively,and significant differences were noted between groups(P

SELECTION OF CITATIONS
SEARCH DETAIL